• 12-Jun-2024

Tourmaline Bio Chief Technology Officer Awarded $1.17M Worth of Stock Options

Grand News Network | October 24, 2023

Dana Susan Jones, Chief Technology Officer at Tourmaline Bio (NASDAQ:TRML), reported a large acquisition of company stock options on October 24, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Jones, Chief Technology Officer at Tourmaline Bio, a company in the Health Care sector, was just awarded stock options worth 122,993 shares of TRML. The options give Jones the right to buy the company's stock at $8.49 per share.

Tourmaline Bio shares are trading up 0.95% at $9.55 at the time of this writing on Tuesday morning. Since the current price is $9.55, this makes Jones's 122,993 shares worth $1,174,583.

Now ...

Full story available on Benzinga.com

Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.

Disclaimer Press Release Banner